Octreotide Injection

342 interactions 555 cited references

Also sold as: Bynfezia Bynfezia® Mycapssa Sandostatin Sandostatin® Sandostatin® LAR Depot

About Octreotide Injection

Octreotide immediate-release injection is used to decrease the amount of growth hormone (a natural substance) produced by people with acromegaly (condition in which the body produces too much growth hormone, causing enlargement of the hands, feet, and facial features; joint pain; and other symptoms) who cannot be treat… Read the full Octreotide Injection drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 10, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dronedarone Levoketoconazole Levomethadyl Mesoridazine Pimozide Ziprasidone

13 Contraindicated 325 Major 4 Moderate

All (342) Contraindicated (13) Major (325) Moderate (4)

Major

Octreotide Injection Saxagliptin Onglyza An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Injection Selpercatinib Retevmo Increased risk of QT interval prolongation Details Octreotide Injection Sematilide An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Octreotide Injection Sertindole An increased risk of cardiotoxicity (QT prolongation, torsade de pointes, cardiac arrest) Details Octreotide Injection Sertraline An increased risk of QT interval prolongation Details Octreotide Injection Sevoflurane Petrem Increased risk of QT interval prolongation Details Octreotide Injection Siponimod Mayzent An increased risk of QT interval prolongation Details Octreotide Injection Sirolimus Felycin Increased exposure of CYP3A4 substrates with narrow therapeutic index Details Octreotide Injection Sitagliptin Brynovin An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Injection Sodium Bicarbonate Alka-Seltzer® Heartburn Decreased octreotide bioavailability Details Octreotide Injection Sodium Phosphate OsmoPrep An increased risk of QT interval prolongation Details Octreotide Injection Sodium Phosphate, Dibasic An increased risk of QT interval prolongation Details Octreotide Injection Sodium Phosphate, Monobasic An increased risk of QT interval prolongation Details Octreotide Injection Solifenacin Vesicare An increased risk of QT interval prolongation Details Octreotide Injection Sonidegib Odomzo Increased exposure of CYP3A4 substrates with narrow therapeutic index Details Octreotide Injection Sorafenib Nexavar An increased risk of QT interval prolongation Details Octreotide Injection Sotalol Betapace An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Octreotide Injection Spiramycin An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Octreotide Injection Sulfamethoxazole Sustain An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Octreotide Injection Sulpiride An increased risk of QT interval prolongation Details Octreotide Injection Sultopride An increased risk of cardiotoxicity (QT prolongation, torsade de pointes, cardiac arrest) Details Octreotide Injection Sunitinib Sutent An increased risk of QT interval prolongation Details Octreotide Injection Tacrolimus Astagraf An increased risk of QT interval prolongation Details Octreotide Injection Taletrectinib Ibtrozi Increased risk of QT interval prolongation and torsade de pointes Details Octreotide Injection Tamoxifen Nolvadex® Increased tamoxifen exposure and an increased risk of QT interval prolongation Details Octreotide Injection Tedisamil An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Octreotide Injection Telavancin Vibativ An increased risk of QT interval prolongation Details Octreotide Injection Telithromycin An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Octreotide Injection Temsirolimus Torisel Increased exposure of CYP3A4 substrates with narrow therapeutic index Details Octreotide Injection Tetrabenazine Xenazine An increased risk of QT interval prolongation Details Octreotide Injection Thiethylperazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Octreotide Injection Tolazamide Tolinase® An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Injection Tolbutamide Orinase® An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Injection Tolvaptan Jynarque Increased exposure of CYP3A4 substrates with narrow therapeutic index Details Octreotide Injection Toremifene Fareston An increased risk of QT interval prolongation, ventricular tachycardia or an increased risk of torsade de pointes Details Octreotide Injection Trazodone Raldesy An increased risk of QT interval prolongation and an increased risk of cardiac arrythmia Details Octreotide Injection Triclabendazole Egaten An increased risk of QT interval prolongation Details Octreotide Injection Trifluoperazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Octreotide Injection Triflupromazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Octreotide Injection Trimeprazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.